Detalhe da pesquisa
1.
Completion pancreatectomy during pancreatoduodenectomy: A lifesaving solution in high-risk patients.
World J Surg
; 48(5): 1123-1131, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38553833
2.
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes?
Liver Int
; 43(3): 546-557, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36571256
3.
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model.
Int J Mol Sci
; 23(24)2022 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36555845
4.
Lysine methylation signaling in pancreatic cancer.
Curr Opin Oncol
; 30(1): 30-37, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29076964
5.
Radiological diagnosis of hepatocellular carcinoma does not preclude biopsy before treatment.
JHEP Rep
; 6(1): 100957, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38234407
6.
Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study.
J Clin Oncol
; 42(9): 1055-1066, 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38232341
7.
Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis.
Cell Discov
; 10(1): 12, 2024 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38296970
8.
Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT).
Eur J Cancer
; 202: 114000, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38493667
9.
Cholangiocarcinoma: what are the options in all comers and how has the advent of molecular profiling opened the way to personalised medicine ?
Eur J Cancer
; 179: 1-14, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36463640
10.
Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis.
bioRxiv
; 2023 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37790557
11.
Safety and Efficacy of Transarterial Chemoembolization in Elderly Patients with Intermediate Hepatocellular Carcinoma.
Cancers (Basel)
; 14(7)2022 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35406406
12.
SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.
Cancer Discov
; 12(9): 2158-2179, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35819319
13.
Structural and Socio-Spatial Determinants Influencing Care and Survival of Patients with a Pancreatic Adenocarcinoma: Results of the PANDAURA Cohort.
Cancers (Basel)
; 14(21)2022 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36358831
14.
Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis.
Cancers (Basel)
; 13(4)2021 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33672012
15.
Lysine Methyltransferases Signaling: Histones are Just the Tip of the Iceberg.
Curr Protein Pept Sci
; 21(7): 655-674, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31894745
16.
From in vitro evaluation to human postmortem pre-validation of a radiopaque and resorbable internal biliary stent for liver transplantation applications.
Acta Biomater
; 106: 70-81, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32014582
17.
Author Correction: Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis.
Cell Discov
; 10(1): 34, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531836
18.
Combination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinoma.
Oncotarget
; 9(13): 11145-11158, 2018 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29541403
19.
Liver immunotolerance and hepatocellular carcinoma: Patho-physiological mechanisms and therapeutic perspectives.
Eur J Cancer
; 87: 101-112, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29145036
20.
Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma.
Mol Cancer Ther
; 16(10): 2157-2165, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28566435